Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)
Phase 1
- Conditions
- healthy subjects
- Registration Number
- JPRN-jRCT2051200123
- Lead Sponsor
- Shimizu Tomohito
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
The subjects will be individuals who meet all of the following criteria.
[1] Healthy men
[2] Individuals >=20 to <45 years of age at the time of informed consent
[3] Individuals who fully understand the details of the study and who are capable of providing written informed consent
Exclusion Criteria
Individuals meeting any of the following criteria will be excluded from the study.
[1] Past history of disease of kidney, liver, heart, brain, or other conditions considered unsuitable for this study
[2] Past history of disease or surgery that could affect absorption of the investigational product or designated concomitant drug
[3]Other protocol defined exclusion criteria could apply
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method